ALPMF News and Press, Astellas Pharma Inc From 05/09/23

2023-05-09 08:56:49 ET Leading drugmakers are prepping for a legal fight against recently implemented U.S. drug pricing reforms which bring negotiating power to Medicare for the first time ever, Reuters reported Tuesday, citing industry sources. In March, the Centers for Medicare &a...

2023-05-01 09:12:47 ET Apellis Pharmaceuticals ( NASDAQ: APLS ) stock weakness, down 7.1% in premarket trading, is a buying opportunity after competitor Iveric Bio ( ISEE ) agreed to be sold to Astellas Pharma ( OTCPK:ALPMF ) for $5.9 billion on Sunday, according to ...

2023-05-01 08:52:41 ET Apellis Pharmaceuticals ( NASDAQ: APLS ) stock weakness, down 7.1% in premarket trading, is a buying opportunity after competitor Iveric Bio ( ISEE ) agreed to be sold to Astellas Pharma ( OTCPK:ALPMF ) for $5.9 billion on Sunday, according to ...

2023-05-01 07:16:39 ET Listen on the go! Subscribe to Wall Street Breakfast on Apple Podcasts and Spotify First Republic Bank ( FRC ) is seized, will be sold to JPMorgan. Nornickel ( NILSY ) board recommends no dividend for first time since 20...

2023-04-29 11:32:07 ET Astellas Pharma Inc. (ALPMF) Q4 2022 Results Conference Call April 27, 2023 03:00 AM ET Company Participants Hiromitsu Ikeda - Corporate Head, Advocacy and Relations Naoki Okamura - Representative Director, President and CEO Yoshitsugu Shit...

2023-04-24 08:39:37 ET For further details see: Lantheus, POINT Biopharma receive FDA Fast Track status for prostate cancer candidate

2023-04-19 06:39:26 ET Summary Biotechnology is the second worst performer in healthcare, significantly lagging behind the US market year-to-date. However, there could now be opportunities to get a bargain in the biotechs. Kura Oncology may be of interest to investors as this US b...

2023-04-04 08:35:08 ET Summary Its lead drug candidate is in Phase 3 development for multiple leukemia indications. Mechanism has utility in other cancer and non-cancer diseases. Perceived trial delays punished the stock. Delays actually raise the odds of greater survival ...

2023-04-01 16:00:21 ET Pfizer's ( NYSE: PFE ) acquisition of Seagen ( NASDAQ: SGEN ), announced in March, is expected to complement the pharma giant's current portfolio of oncology therapies. Seagen focuses on antibody-drug conjugates (ADCs), a technology that the co...

2023-03-29 04:41:23 ET Astellas Pharma ( OTCPK:ALPMF ) ( OTCPK:ALPMY ) is collaborating with Roche Diabetes Care Japan to develop and commercialize Roche's Accu-Chek Guide Me blood glucose monitoring system as a combined product with an app called BlueStar. Astellas s...